Why is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Cancer

• Publication date

  2017-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.30766PMID 28477390
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The evolving role of microsatellite instability in colorectal cancer: A review.

  2016cited by this paper
• Conditional Survival: A Useful Concept to Provide Information on How Prognosis Evolves over Time

  2015cited by this paper
• When do changes in cancer survival mean progress? The insight from population incidence and mortality.

  2014influential reference
• Cause of death the first year after curative colorectal cancer surgery; a prolonged impact of the surgery in elderly colorectal cancer patients.

  2014cited by this paper
• Association between socioeconomic status, surgical treatment and mortality in patients with colorectal cancer

  2014cited by this paper
• Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.

  2014cited by this paper
• Early mortality from colorectal cancer in England: a retrospective observational study of the factors associated with death in the first year after diagnosis

  2013cited by this paper
• Early recurrence in patients undergoing curative surgery for colorectal cancer: is it a predictor for poor overall survival?

  2013cited by this paper
• Risk Factors for Excess Mortality in the First Year After Curative Surgery for Colorectal Cancer

  2012cited by this paper
• Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study

  2012influential reference
• Colorectal cancer survival in socioeconomic groups in England: variation is mainly in the short term after diagnosis.

  2012cited by this paper
• Association of symptoms of colon cancer patients with tumor location and TNM tumor stage

  2012cited by this paper
• Investigation of ABCB1 1236 and 2677 SNPs in patients with peptic ulcer

  2012cited by this paper
• Trends in colorectal cancer incidence in Norway 1962–2006: an interpretation of the temporal patterns by anatomic subsite

  2010cited by this paper
• An Evaluation of the Relationship Between Lymph Node Number and Staging in pT3 Colon Cancer Using Population-Based Data

  2010cited by this paper
• Timing of Relapse and Outcome after Curative Resection for Colorectal Cancer: A Japanese Multicenter Study

  2009cited by this paper
• Comparative cancer survival information in Europe.

  2009cited by this paper
• The Importance of Tumor Stage and Relative Survival Analysis for the Association Between Sex and Survival After Resection of Colorectal Cancer

  2009cited by this paper
• Treatment in advanced colorectal cancer: what, when and how?

  2009cited by this paper
• Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

  2008cited by this paper
• Trends in colorectal cancer survival in northern Denmark: 1985–2004

  2007cited by this paper
• Improved survival in cancer of the colon and rectum in Sweden.

  2005cited by this paper
• An Icelandic example of the impact of population structure on association studies

  2005cited by this paper
• The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies.

  2004cited by this paper
• New chemotherapeutic advances in pancreatic, colorectal, and gastric cancers.

  2004cited by this paper
• World Cancer Report

  2003cited by this paper
• Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

  2000cited by this paper
• [Delay in the diagnosis of colon cancer, associated with staging and prognosis. A retrospective study from Landspitalinn University Hospital 1980-1992.].

  1996cited by this paper
• Synchronous colon primaries have the same prognosis as solitary colon cancers

  1996cited by this paper
• Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries.

  1993cited by this paper
• [Prognostic factors of colorectal cancer].

  1989cited by this paper
• The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

  1985cited by this paper
• Cancer of the colon: The influence of theno‐touch isolation technic on survival rates

  1968cited by this paper
• Cancer of the colon: the influence of the no-touch isolation technic on survival rates.

  1967cited by this paper
• Carcinoma of the Colon and Rectum.

  1942cited by this paper

• Immunotherapy in Stage III–IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database

  2024cites this paper
• CELF6 as an Oncogene in Colorectal Cancer: Targeting Stem-Cell-Like Properties Through Modulation of HOXA5 mRNA Stability.

  2024cites this paper
• CD69+CD103+CD8+ tissue-resident memory T cells possess stronger anti-tumor activity and predict better prognosis in colorectal cancer

  2024cites this paper
• The E3 ubiquitin ligase SCF (FBXW10)-mediated LATS2 degradation regulates angiogenesis and liver metastasis in colorectal cancer.

  2023cites this paper
• The exploration of mitochondrial‐related features helps to reveal the prognosis and immunotherapy methods of colorectal cancer

  2023cites this paper
• SCF‐FBXL8 contributes to liver metastasis and stem‐cell‐like features in colorectal cancer cells by mediating ubiquitination and degradation of TP53

  2023cites this paper
• Construction and validation of a prognostic nomogram for predicting cancer-specific survival in patients with intermediate and advanced colon cancer after receiving surgery and chemotherapy

  2023cites this paper
• Oral Tegafur-Uracil Combination plus Leucovorin versus Other Fluoropyrimidine Agents in Colorectal Cancer: A Systematic Review and Meta-Analysis

  2022cites this paper
• Hsa_Circ_0104206 is An Oncogenic circRNA in Colon Cancer by Targeting Mir-188–3p/CCNA2 Axis

  2022cites this paper
• HEIGO REIMA Colorectal cancer care and outcomes – evaluation and possibilities for improvement in Estonia

  2022cites this paper
• Colorectal Cancer Prevalence and Survival in Cuenca (Spain)

  2022cites this paper
• MTBP promoted the proliferation, migration and invasion of colon cancer cells by activating the expression of ZEB2

  2021cites this paper
• Trends in Tumor Site-Specific Survival of Bone Sarcomas from 1980 to 2018: A Surveillance, Epidemiology and End Results-Based Study

  2021cites this paper
• A Modified Tumor-Node-Metastasis Classification for Primary Operable Colorectal Cancer

  2020cites this paper
• Colorectal liver metastases: Current management and future perspectives

  2020cites this paper
• Survival Trends After Surgery for Spinal Metastatic Tumors: 20-Year Cancer Center Experience.

  2020cites this paper
• Klotho and the Treatment of Human Malignancies

  2020cites this paper
• LncRNA NR2F1-AS1 Regulates miR-371a-3p/TOB1 Axis to Suppress Proliferation of Colorectal Cancer Cells

  2020cites this paper
• Temporal recalibration for improving prognostic model development and risk predictions in settings where survival is improving over time

  2020cites this paper
• Oncologic and Perioperative Outcomes of Laparoscopic, Open, and Robotic Approaches for Rectal Cancer Resection: A Multicenter, Propensity Score-Weighted Cohort Study.

  2019cites this paper
• Influence of primary tumour and patient factors on survival in patients undergoing curative resection and treatment for liver metastases from colorectal cancer

  2019cites this paper
• LncRNA GAS8-AS inhibits colorectal cancer (CRC) cell proliferation by downregulating lncRNA AFAP1-AS1.

  2019cites this paper
• Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer

  2019cites this paper
• New insights into molecular mechanisms of rosiglitazone in monotherapy or combination therapy against cancers.

  2018cites this paper
• Klotho suppresses colorectal cancer through modulation of the unfolded protein response

  2018cites this paper
• Subsite- and stage-specific colorectal cancer trends in Estonia prior to implementation of screening.

  2018cites this paper